 TUCSON, Ariz., Dec. 23, 2022 GLOBE NEWSWIRE HTG Molecular Diagnostics, Inc. Nasdaq: HTGM HTG, a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced the closing of its previously announced public offering of an aggregate of 1,290,322 shares of its common stock or pre-funded warrants ... The post HTG Molecular Diagnostics Announces Closing of a 10 Million Public Offering appeare... 